166 related articles for article (PubMed ID: 21665301)
1. Recombinant lactic acid bacteria as mucosal biotherapeutic agents.
Daniel C; Roussel Y; Kleerebezem M; Pot B
Trends Biotechnol; 2011 Oct; 29(10):499-508. PubMed ID: 21665301
[TBL] [Abstract][Full Text] [Related]
2. Engineering Tools for the Development of Recombinant Lactic Acid Bacteria.
Cho SW; Yim J; Seo SW
Biotechnol J; 2020 Jun; 15(6):e1900344. PubMed ID: 31995278
[TBL] [Abstract][Full Text] [Related]
3. Lactic acid bacteria as oral delivery systems for biomolecules.
Berlec A; Ravnikar M; Strukelj B
Pharmazie; 2012 Nov; 67(11):891-8. PubMed ID: 23210237
[TBL] [Abstract][Full Text] [Related]
4. Food-grade gene expression in lactic acid bacteria.
Peterbauer C; Maischberger T; Haltrich D
Biotechnol J; 2011 Sep; 6(9):1147-61. PubMed ID: 21858927
[TBL] [Abstract][Full Text] [Related]
5. Genetic tools for the development of recombinant lactic acid bacteria.
Wu J; Xin Y; Kong J; Guo T
Microb Cell Fact; 2021 Jun; 20(1):118. PubMed ID: 34147119
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of lactic acid bacteria on human beings.
Masood MI; Qadir MI; Shirazi JH; Khan IU
Crit Rev Microbiol; 2011 Feb; 37(1):91-8. PubMed ID: 21162695
[TBL] [Abstract][Full Text] [Related]
7. Recombinant lactic acid bacteria as delivery vectors of heterologous antigens: the future of vaccination?
Trombert A
Benef Microbes; 2015; 6(3):313-24. PubMed ID: 25245573
[TBL] [Abstract][Full Text] [Related]
8. Lactic acid bacteria: reviewing the potential of a promising delivery live vector for biomedical purposes.
Cano-Garrido O; Seras-Franzoso J; Garcia-Fruitós E
Microb Cell Fact; 2015 Sep; 14():137. PubMed ID: 26377321
[TBL] [Abstract][Full Text] [Related]
9. Engineering lactococci and lactobacilli for human health.
Bermúdez-Humarán LG; Aubry C; Motta JP; Deraison C; Steidler L; Vergnolle N; Chatel JM; Langella P
Curr Opin Microbiol; 2013 Jun; 16(3):278-83. PubMed ID: 23850097
[TBL] [Abstract][Full Text] [Related]
10. In vivo mucosal delivery of bioactive human interleukin 1 receptor antagonist produced by Streptococcus gordonii.
Ricci S; Macchia G; Ruggiero P; Maggi T; Bossù P; Xu L; Medaglini D; Tagliabue A; Hammarström L; Pozzi G; Boraschi D
BMC Biotechnol; 2003 Sep; 3():15. PubMed ID: 13129437
[TBL] [Abstract][Full Text] [Related]
11. Current issues regarding the application of recombinant lactic acid bacteria to mucosal vaccine carriers.
Takahashi K; Orito N; Tokunoh N; Inoue N
Appl Microbiol Biotechnol; 2019 Aug; 103(15):5947-5955. PubMed ID: 31175431
[TBL] [Abstract][Full Text] [Related]
12. Delivery of therapeutic proteins to the mucosa using genetically modified microflora.
Steidler L
Expert Opin Drug Deliv; 2005 Jul; 2(4):737-46. PubMed ID: 16296798
[TBL] [Abstract][Full Text] [Related]
13. [Advances in the use of lactic acid bacteria as mucosal delivery vectors of therapeutic molecules].
Zeng Z
Sheng Wu Gong Cheng Xue Bao; 2021 Jul; 37(7):2272-2282. PubMed ID: 34327894
[TBL] [Abstract][Full Text] [Related]
14. Mucosal targeting of therapeutic molecules using genetically modified lactic acid bacteria: an update.
LeBlanc JG; Aubry C; Cortes-Perez NG; de Moreno de LeBlanc A; Vergnolle N; Langella P; Azevedo V; Chatel JM; Miyoshi A; Bermúdez-Humarán LG
FEMS Microbiol Lett; 2013 Jul; 344(1):1-9. PubMed ID: 23600579
[TBL] [Abstract][Full Text] [Related]
15. Genomics of lactic acid bacteria: Current status and potential applications.
Wu C; Huang J; Zhou R
Crit Rev Microbiol; 2017 Aug; 43(4):393-404. PubMed ID: 28502225
[TBL] [Abstract][Full Text] [Related]
16. Production of Gamma-Aminobutyric Acid from Lactic Acid Bacteria: A Systematic Review.
Cui Y; Miao K; Niyaphorn S; Qu X
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32028587
[TBL] [Abstract][Full Text] [Related]
17. Metabolic engineering as a tool for enhanced lactic acid production.
Upadhyaya BP; DeVeaux LC; Christopher LP
Trends Biotechnol; 2014 Dec; 32(12):637-44. PubMed ID: 25457813
[TBL] [Abstract][Full Text] [Related]
18. Evolution of lactic acid bacteria in the order Lactobacillales as depicted by analysis of glycolysis and pentose phosphate pathways.
Salvetti E; Fondi M; Fani R; Torriani S; Felis GE
Syst Appl Microbiol; 2013 Jul; 36(5):291-305. PubMed ID: 23735786
[TBL] [Abstract][Full Text] [Related]
19. Lactic acid bacteria as mucosal delivery vehicles: a realistic therapeutic option.
Wang M; Gao Z; Zhang Y; Pan L
Appl Microbiol Biotechnol; 2016 Jul; 100(13):5691-701. PubMed ID: 27154346
[TBL] [Abstract][Full Text] [Related]
20. Use of genetically modified lactic acid bacteria and bifidobacteria as live delivery vectors for human and animal health.
Levit R; Cortes-Perez NG; de Moreno de Leblanc A; Loiseau J; Aucouturier A; Langella P; LeBlanc JG; Bermúdez-Humarán LG
Gut Microbes; 2022; 14(1):2110821. PubMed ID: 35960855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
